[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346397-105":59,"doc-detail-346397-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ubiquitination-of-oncogenic-mutant-p53-via-attenuation-of-ribosome-biogenesis-machinery-effectively-inhibits-pancreatic-tumor-growth","Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth","","Pancreatic cancer is a highly lethal malignancy with limited treatment success, and hyperactivated ribosome biogenesis (RiBi) is linked to poor prognosis. This study evaluates BMH-21, an RNA polymerase I inhibitor, and shows that it induces apoptosis and growth inhibition in pancreatic cancer cells while sparing normal pancreatic ductal epithelial cells. Mechanistically, BMH-21 degrades RPA194, suppresses pre-rRNA synthesis, promotes mutant p53 ubiquitination without affecting wild-type p53, and reduces orthotopic xenograft tumor growth with no observed toxicity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ubiquitination-of-oncogenic-mutant-p53-via-attenuation-of-ribosome-biogenesis-machinery-effectively-inhibits-pancreatic-tumor-growth/346397/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ubiquitination-of-oncogenic-mutant-p53-via-attenuation-of-ribosome-biogenesis-machinery-effectively-inhibits-pancreatic-tumor-growth/346397.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main therapeutic focus of the study?","Question",{"text":112,"@type":113},"The study focuses on BMH-21 as a pharmacologic inhibitor of RNA polymerase I to target pancreatic cancer by disrupting ribosome biogenesis-related mechanisms.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does BMH-21 affect pancreatic cancer cells compared with normal cells?",{"text":117,"@type":113},"BMH-21 selectively induces apoptosis and inhibits cell growth in pancreatic cancer cells without affecting normal human pancreatic ductal epithelial cells.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism links BMH-21 to mutant p53 ubiquitination?",{"text":121,"@type":113},"BMH-21 degrades RPA194 and inhibits RPA194/RPA135 recruitment on rDNA, which suppresses pre-rRNA synthesis and selectively exposes truncated, mutated p53 for ubiquitination while not altering wild-type p53 ubiquitination.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346397,1790173652,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth  \nMudassier Ahmad1,2, Sahir Sultan Alvi1,2, Haider Ahsan1, Carlos Perez1,3, Andrew Massey4,  \nVivek K. Kashyap1,2, Neeraj Chauhan1, Emmanuel Anning1,3, Manish K. Tripathi1,2, Dae J. Kim1,2,3, Nirakar Sahoo5, Tamer Oraby6, Murali M. Yallapu1,2, Mohammad Moshahid Khan7, Manu M. Sebastian8, Subhash C. Chauhan1,2, and Bilal B. Hafeez1,2  \n|  |  | A |  | B | S |  | T | R |  | A |  | C | T |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n|  | Dysregulated ribosome biogenesis and p53 mutations are known to play oncogenic roles in various cancers, including pancreatic cancer. In this study, we demonstrated the therapeutic potential of BMH-21, a pharmacologic inhibitor of RNA polymerase I, against pancreatic cancer by uncovering a novel molecular mechanism involving RPA194-mediated ubiquitination of mutant p53 without affecting the ubiquitination of wild-type p53 . Our key findings are that (i) BMH-21 selectively induces apoptosis and cell growth inhibition of pancreatic cancer cells with no effect on normal human pancreatic ductal epithelial cells; (ii) BMH-21 degrades RPA194; (iii) BMH-21 inhibits recruitment of\u003Cbr>􀀶 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | both RPA194 and RPA135 on rDNA to suppress pre-rRNA synthesis; (iv) RPA194 physically interacts with p53 and BMH- 21–induced degradation of RPA194 selectively exposes truncated and mutated p53 for ubiquitination with no effect on ubiquitination of wild-type p53 in pancreatic cancer cells; and (v) BMH-21 treatment significantly reduces the growth of orthotopic xenograft pancreatic tumors in athymic nude mice with no observed toxicity. Altogether, these findings suggest that BMH-21 is a promising, nontoxic therapeutic agent for patients with pancreatic cancer with aberrant ribosome biogenesis and mutant p53, offering a potential new avenue for targeted treatment. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n\nIntroduction  \nPancreatic cancer remains one of the most lethal malignancies, with an overall survival rate ranging from only 2% to 9% due to the lack of effective therapies (1). The FDA-approved current therapeutic regimens such as 5-fluorouracil (5-FU), gemcitabine, ABRAXANE (albumin-bound paclitaxel), FOLFIRINOX (a combination of 5-FU, irinotecan, and oxaliplatin), ONIVYDE (a liposomal injection of irinotecan used in combination with 5-FU and leucovorin), and NALIRIFOX (a combination of nanoliposomal irinotecan, 5-FU,  \n1Department of Medicine and Oncology, School of Medicine, UTRGV, McAllen, Texas. 2South Texas Center of Excellence in Cancer Research, School of Medicine, UTRGV, McAllen, Texas. 3Graduate Program in Biochemistry and Molecular Biology, UTRGV, Edinburg, Texas. 4Section on Mechanobiology, National Institute of Biomedical Imaging and Bioengineering, Bethesda, Maryland. 5School of Integrative Biological and Chemical Sciences, UTRGV,","cbCaii2uFH5CUVnj","https://ap.wps.com/l/cbCaii2uFH5CUVnj","pdf",22596462,15,"English","# Introduction\n## Pancreatic cancer treatment limitations and prognosis\n## Hyperactivated ribosome biogenesis (RiBi) as a therapeutic target\n## RNA polymerase I (Pol I) components and rationale for inhibition","[{\"question\":\"What is the main therapeutic focus of the study?\",\"answer\":\"The study focuses on BMH-21 as a pharmacologic inhibitor of RNA polymerase I to target pancreatic cancer by disrupting ribosome biogenesis-related mechanisms.\"},{\"question\":\"How does BMH-21 affect pancreatic cancer cells compared with normal cells?\",\"answer\":\"BMH-21 selectively induces apoptosis and inhibits cell growth in pancreatic cancer cells without affecting normal human pancreatic ductal epithelial cells.\"},{\"question\":\"What mechanism links BMH-21 to mutant p53 ubiquitination?\",\"answer\":\"BMH-21 degrades RPA194 and inhibits RPA194/RPA135 recruitment on rDNA, which suppresses pre-rRNA synthesis and selectively exposes truncated, mutated p53 for ubiquitination while not altering wild-type p53 ubiquitination.\"}]","Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth | PDF",1790061269,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b099b1975a0085955fdc4906bb9d2251.webp",983,1315,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/82a44632f96f601a576f78ab27695cca.webp",982,1314,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/924e976ac08274b8c5cfdc9c0a30c6a7.webp",981,1312,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/924bb6324401799f087dcc514eb108c2.webp",980,1311]